Open sidebar
Focus
molnupiravir
COVID Treatments & Remedies
|
Aldgra Fredly
Study Finds Paxlovid, Molnupiravir Reduce Omicron Hospitalization, Mortality
Researchers said that both oral antiviral drugs can be used to treat nonhospitalized patients at high risk of progressing to severe COVID-19.
Sep 22, 2023
|
Aldgra Fredly
Sep 22
|
COVID News
|
Katabella Roberts
Merck’s COVID-19 Antiviral Drug Doesn’t Reduce Hospitalization or Death in High-Risk Vaccinated People: Study
Dec 26, 2022
|
Katabella Roberts
Dec 26
|
Research & Discoveries
|
Liane Lau
Hong Kong Study of Oral Antivirals Shows Promise for Omicron Patients
Oct 11, 2022
|
Liane Lau
Oct 11
|
Health Viewpoints
|
Joseph Mercola
COVID Pills Cause Deadly Relapses and Supercharge Mutations
May 11, 2022
|
Joseph Mercola
May 11
|
Businesses in COVID-19
|
Reuters
Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
Feb 04, 2022
|
Reuters
Feb 04
|
Companies
|
Reuters
Merck Expects COVID-19 Pill Molnupiravir to Be Effective Against Omicron
Jan 12, 2022
|
Reuters
Jan 12
|
Businesses in COVID-19
|
Naveen Athrappully
Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills
Jan 05, 2022
|
Naveen Athrappully
Jan 05
|
India News
|
Reuters
India Boosts Arsenal Against COVID-19 With Merck Pill, 2 More Vaccines
Dec 29, 2021
|
Reuters
Dec 29
|
Companies
|
Reuters
France Cancels Order for Merck’s COVID-19 Antiviral Drug
Dec 24, 2021
|
Reuters
Dec 24
|
US News
|
Mimi Nguyen Ly
FDA Advisers Vote to Recommend Merck COVID-19 Pill for Emergency Use Authorization
Nov 30, 2021
|
Mimi Nguyen Ly
Nov 30
|
Health
|
Reuters
WHO Says Seeks More Data From Merck on COVID-19 Anti-Viral, From Bharat on Vaccine
Oct 29, 2021
|
Reuters
Oct 29
|
CCP Virus
|
The Associated Press
Merck Asks EU Regulator to Authorize Pill That Treats COVID-19
Oct 25, 2021
|
The Associated Press
Oct 25
|
